Published in Br J Dermatol on May 01, 1997
Rituximab in the Treatment of Patients With Bullous Pemphigoid | NCT00286325
Frequency of Neurological Disorders in Bullous Pemphigoid Patients: A Cross-Sectional Study. Int Sch Res Notices (2017) 0.75
Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis. Arch Dermatol Res (2017) 0.75
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol (1995) 2.37
Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol (1989) 2.25
Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Br J Cancer (1999) 1.96
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
[Does bullous pemphigoid with negative direct immunofluorescence exist? Apropos of 3 cases]. Ann Dermatol Venereol (1992) 1.40
Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39
Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol (1989) 1.21
Bier's white spots associated with scleroderma renal crisis. Clin Exp Dermatol (2006) 1.17
Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol (1996) 1.04
Aortic angiosarcoma clinically mimicking polyarteritis nodosa. Scand J Rheumatol (2006) 1.02
Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99
Dermatomyositis and malignancy. J Invest Dermatol (1993) 0.98
[Giant buccal aphthosis caused by nicorandil]. Presse Med (1997) 0.96
Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol (1990) 0.96
Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol (2004) 0.96
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95
[Anticytoplasmic antibodies of human epidermal cells (author's transl)]. Ann Dermatol Venereol (1977) 0.93
Melorheostosis with associated minimal change nephrotic syndrome, mesenteric fibromatosis and capillary haemangiomas. Dermatology (1994) 0.93
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92
Oral nicorandil-induced lesions are not aphthous ulcers. J Oral Pathol Med (2003) 0.91
The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol (1991) 0.89
Skin antibodies in bone marrow transplanted patients. Clin Exp Dermatol (1976) 0.88
[Bacterial dermo-hypodermatitis in adults. Incidence and role of streptococcal etiology]. Ann Dermatol Venereol (1995) 0.88
[Immunofluorescence in temporal arteritis]. N Engl J Med (1978) 0.87
Treatment of verrucous carcinoma with recombinant alfa-interferon. Dermatology (1995) 0.85
[Drug hypersensitive syndrome caused by fluindione]. Ann Dermatol Venereol (2001) 0.84
Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol (2010) 0.84
Acquired ichthyosis and pyoderma gangrenosum in a patient with systemic lupus erythematosus. Clin Exp Dermatol (1993) 0.84
Postoperative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 treated scars. Dermatology (1997) 0.83
Urticarial vasculitis induced by fluoxetine. Dermatology (1995) 0.83
[Methi-resistant Staphylococcus aureus in dermatological practice: origin, risk factors and outcome]. Ann Dermatol Venereol (2002) 0.83
Familial aquagenic urticaria. Dermatologica (1979) 0.83
[Verrucous carcinoma of the lower limbs]. Ann Dermatol Venereol (2007) 0.82
[Drug-induced hypersensitivity syndrome in internal medicine: diagnostic and therapeutic traps. Eight observations]. Rev Med Interne (2000) 0.82
Dermo-hypodermal bacterial infections. Current concepts. Eur J Med (1992) 0.82
Alopecia areata occurring in a patient receiving systemic cyclosporin A. Acta Derm Venereol (1994) 0.82
[Primary cutaneous large B-cell lymphoma in chronic venous leg ulcer]. Ann Dermatol Venereol (2007) 0.81
[Bevacizumab therapy for Poems syndrome]. Ann Dermatol Venereol (2008) 0.81
HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Eur J Dermatol (1998) 0.81
[Survival prognosis in pemphigoid. A cohort analysis of 78 patients]. Ann Dermatol Venereol (1995) 0.81
Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol (1990) 0.81
[Pemphigoid vegetans. An immunoelectron microscopic study]. Ann Dermatol Venereol (1997) 0.81
A proliferative vascular tumour of the skin in a kidney-transplant recipient (recurrent pyogenic granuloma with satellitosis). Nephrol Dial Transplant (1997) 0.81
Early detection of streptococcal group antigens in skin samples by latex particle agglutination. Arch Dermatol (1987) 0.80
Thalidomide and recurrent aphthous stomatitis: a follow-up study. Dermatology (1996) 0.80
[Cushing's syndrome induced by local corticotherapy in an infant]. Nouv Presse Med (1978) 0.80
The naevoid basal-cell carcinoma syndrome (Gorlin syndrome) is a chromosomal instability syndrome. Mutat Res (1998) 0.80
Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol (1990) 0.79
Dimethyl sulphoxide and macular amyloidosis. Acta Derm Venereol (1980) 0.79
Simvastatin-induced lichenoid drug eruption. Clin Exp Dermatol (1994) 0.79
[Prenatal diagnosis of hereditary bullous epidermolysis. A case report]. J Gynecol Obstet Biol Reprod (Paris) (1996) 0.78
Immunofluorescent studies of gastrointestinal tract mucosa in bullous pemphigoid. Arch Dermatol (1986) 0.78
Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin. Arch Dermatol (1995) 0.78
[Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients]. Ann Dermatol Venereol (1996) 0.78
[Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. Ann Dermatol Venereol (2011) 0.78
[Intra-epidermal neutrophilic IgA dermatosis associated with IgA myeloma]. Ann Dermatol Venereol (1990) 0.77
[Photodynamic therapy for the treatment of extramammary Paget's disease]. Ann Dermatol Venereol (2011) 0.77
Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. J Invest Dermatol (1991) 0.77
Binding of autoantibodies is not restricted to desmosomes in pemphigus vulgaris: comparison of 14 cases of pemphigus vulgaris and 10 cases of pemphigus foliaceus studied by western immunoblot and immunoelectron microscopy. Arch Dermatol Res (1996) 0.77
[Predisposing factors in cutaneous reactions to drugs]. Ann Dermatol Venereol (1995) 0.77
[Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]. Ann Dermatol Venereol (2003) 0.77
Acquired ichthyosis with pravastatin. J Eur Acad Dermatol Venereol (2007) 0.77
Evidence of chromosomal instability in the lymphocytes of Gorlin basal-cell carcinoma patients. Mutat Res (1995) 0.77
Benzoyl peroxide in seborrheic dermatitis. Arch Dermatol (1986) 0.77
[Cutaneous reactions to gold salts]. Ann Dermatol Venereol (1994) 0.76
Urticaria with macroglobulinaemia. Disease activity associated alterations in immunoglobulins profile and bone marrow hypodiploidy. Dermatologica (1990) 0.76
[Analysis of the literature about drug-induced aphthous ulcers]. Ann Dermatol Venereol (2000) 0.76
[Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases]. Ann Dermatol Venereol (1986) 0.76
Intracranial hypertension with etretinate. Lancet (1983) 0.76
[Bullous pemphigoid in young patients: a retrospective study of 74 cases]. Ann Dermatol Venereol (2005) 0.76
[Hematologic effects of dapsone (Disulone)]. Rev Med Interne (1991) 0.76
[Disulon in the treatment of Horton's disease. Experience with 20 patients]. Ann Med Interne (Paris) (1986) 0.76
Bullous lichen sclerosus with chronic hepatitis C virus infection. Br J Dermatol (1997) 0.76
Blood eosinophilia as a severity marker for bullous pemphigoid. J Am Acad Dermatol (1987) 0.75
Adverse effects associated with EMLA cream used as topical anesthetic for the mechanical debridement of leg ulcers. J Am Acad Dermatol (2000) 0.75
[Betablockers and skin (author's transl)]. Ann Dermatol Venereol (1979) 0.75
Hypocomplementemia in keratoacanthoma. Arch Dermatol Res (1981) 0.75
Dapsone and rheumatoid vasculitis leg ulcerations. J Am Acad Dermatol (1988) 0.75
Lymphomatoid papulosis type D: an aggressive histology for an indolent disease. Br J Dermatol (2013) 0.75
[What is your diagnosis? Orf of pyogenic granuloma type]. Ann Dermatol Venereol (1988) 0.75
[Articular manifestations in erythema multiforme]. Presse Med (1983) 0.75